Loading...
Loading...
Application UK00913764071 · Dead
| Application Number | UK00913764071 |
| Status | Dead |
| Owner | Immunovia AB |
| Filed | 2015-02-23 |
| Registered | 2015-06-17 |
| Renewal Due | 2025-02-23 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
IMMray has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Sanitary preparations for medical use; Indicators for medical diagnosis; Diagnostic preparations for medical purposes; Diagnostic reagents for medical use; Chemical reagents for the diagnosis of cancer; Chemical reagents for the diagnosis of pancreatic cancer; Chemical reagents for the diagnosis of breast cancer; Chemical reagents for the diagnosis of prostate cancer; Chemical reagents for the diagnosis of auto-immune diseases; Pharmaceutical preparations.
Computer software for diagnosis of disease; Computer software for diagnosing of cancer diseases; Computer software for diagnosing of pancreatic cancer; Computer software for diagnosing of breast cancer; Computer software for diagnosing of prostate cancer; Computer software for diagnosing of auto-immune diseases; DNA chips.
Surgical, medical, veterinary and dental apparatus and instruments; Diagnostic, examination, and monitoring equipment; Diagnostic apparatus for medical purposes; Sensor apparatus for medical use in diagnosis; Apparatus for carrying-out diagnostic tests for medical purposes; Equipment for diagnosis of cancer; Equipment for diagnosis of pancreatic cancer; Equipment for diagnosis of breast cancer; Equipment for diagnosis of prostate cancer; Equipment for diagnosis of auto-immune diseases; Membrane test plates for use in medical research; Analysers for medical use.
Medical research services; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the area of pancreatic cancerous diseases; Scientific research for medical purposes in the area of breast cancerous diseases; Scientific research for medical purposes in the area of prostate cancerous diseases; Scientific research for medical purposes in the area of auto-immune diseases; Computer aided diagnostic testing services; Research and development of computer software.
Medical analysis services; Performing diagnosis of diseases; Medical services for the diagnosis of conditions of the human body; Performing diagnosis of cancer; Performing diagnosis of pancreatic cancer; Performing diagnosis of breast cancer; Performing diagnosis of prostate cancer; Performing diagnosis of auto-immune diseases.
'IMMray' is a dead trademark on the UK IPO register, owned by Immunovia AB. The application (UK00913764071) was filed on 23 February 2015 and registered on 17 June 2015. The registration is set to expire on 23 February 2025.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 9 (scientific, electrical & IT apparatus); Class 10 (medical & surgical apparatus); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Zacco UK Ltd.
UK trademark UK00913764071 for the mark 'IMMray' in Class 5, 9, 10, 42, 44 is recorded on the UK IPO register as owned by Immunovia AB. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00913764071 for the mark 'IMMray' as dead.
UK trademark UK00913764071 for the mark 'IMMray' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 9 (scientific, electrical & IT apparatus); Class 10 (medical & surgical apparatus); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Sanitary preparations for medical use; Indicators for medical diagnosis; Diagnostic preparations for medical purposes; Diagnostic reagents for medical use; Chemical reagents for the diagnosis of cancer; Chemical reagents for the diagnosis of pancreatic cancer; Chemical reagents for the diagnosis of breast c…
UK trademark UK00913764071 for the mark 'IMMray' was filed at the UK IPO on 23 February 2015 and registered on 17 June 2015.
UK trademark UK00913764071 for the mark 'IMMray' is currently recorded as valid until 23 February 2025, at which point it will need to be renewed with the UK IPO to remain in force.
Zacco UK Ltd is listed as the attorney / representative of record for UK trademark UK00913764071 for the mark 'IMMray' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "IMMray" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| IMMRAYSame applicant | 79176421 | 706 | 2015-08-24 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.